Corcept Therapeutics (CORT, $23.88) was one of the top gainers this week, climbing to $23.88 per share. A.I.dvisor analyzed 915 stocks in the Biotechnology Industry over the last week and discovered that of them (7) trended up while of them (2) trended down. A.I.dvisor found 210 similar cases when CORT's price jumped over within one week. In out of those 210 cases, CORT's price went up during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend continuation for CORT are